Syneos Health to Host Virtual Analyst and Investor Event on December 8, 2020

Rhea-AI Summary

Syneos Health (Nasdaq:SYNH) announced it will host an Analyst and Investor Event on December 8, 2020, from 9:00 a.m. to 11:30 a.m. EST. The virtual event will feature presentations from company leadership detailing their unique product development model and plans for growth in the healthcare sector. The event will be accessible via a live webcast on the company's Investor Relations website, featuring audio, video, and presentation materials. The aim is to enhance communication with investors and showcase Syneos' integrated solutions for biopharmaceutical development.

News Market Reaction – SYNH

+1.09%

+1.09% Session move

In the trading session that priced this news, SYNH gained 1.09%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MORRISVILLE, N.C., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Syneos Health^® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), will host an Analyst and Investor Event on Tuesday, December 8, 2020, from 9:00 a.m. to approximately 11:30 a.m. EST.

The event, to be held virtually, will include presentations from Syneos Health leadership about the Company’s unique product development model and plan to drive accelerated growth in the evolving healthcare environment.

A live webcast, including audio, video, presentation materials and an archived replay, will be available on the Company’s Investor Relations website at investor.syneoshealth.com. Participants can pre-register and also access the webcast directly at SyneosHealthInvestorDay.com.

About Syneos Health
Syneos Health^® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life^®, visit syneoshealth.com or subscribe to our podcast.

Contacts
Investor Relations:	Press/Media:
Ronnie Speight	Danielle DeForge
Senior Vice President, Investor Relations	Vice President, External Communications
+1 919 745 2745	+1 202 210 5992
Investor.Relations@syneoshealth.com	danielle.deforge@syneoshealth.com

 

FAQ

What is the date and time of the Syneos Health Analyst and Investor Event?

The Analyst and Investor Event will be held on December 8, 2020, from 9:00 a.m. to 11:30 a.m. EST.

How can I participate in the Syneos Health Investor Event?

You can participate by accessing the live webcast available on Syneos Health's Investor Relations website.

What topics will be covered during the Syneos Health event?

The event will cover Syneos Health's unique product development model and strategies for accelerating growth in the healthcare market.

Where can I find the webcast of the Syneos Health event?

The webcast will be available on the Syneos Health Investor Relations website, including audio, video, and presentation materials.

What is the significance of the Syneos Health event for investors?

The event aims to enhance investor understanding of Syneos Health’s integrated solutions and growth strategies in biopharmaceutical development.